Multicentre, national, observational, retrospective and prospective study.

The BLITZ-COVID19 study aims at describing the epidemiology of admissions to Italian Cardiology Intensive Care Units in the COVID-19 infection pandemia, the main aspects of the clinical management of inpatients, their short-term outcome, the absorption of resources related to their admission.

The BLITZ-COVID19 study, aims at describing the epidemiology of admissions to Italian Cardiology Intensive Care Units .

The study is observational, multicentre, national and involves the collection of clinical data, both retrospectively and prospectively, using a web-based system. In conducting the study, no drugs are tested, nor are diagnostic tests or non-pharmacological therapies performed other than those that each participating cardiologist decides to perform following the rules of normal clinical practice. Diagnostic procedures and pharmacological and non-pharmacological therapies habitually prescribed for cardiovascular pathologies, which are the object of hospitalization, and those used in the event of a COVID-19 infection, will be recorded in the database.

Inclusion Criteria:

- All patients aged ≥18 years admitted with any diagnosis to one of the participating ICU

Exclusion Criteria:

- Refuse to signe consent

All patients aged ≥18 years admitted with any diagnoses to ICU in the specified periods of 30 days each.

Retrospecitve phase:(March 1-30, 2020 in the Northern or Centre-North regions; March 15-April 13, 2020 in the Southern or Ventre_South Regions and island.

Perspective phase (depending by the IRB approval) in the following periods:

November 9-December 8, 2020; November 23-December 22, 2020; January 11-February 9, 2021.

(Retrospective study) or in the

Still to be decided